AGÕæÈ˹ٷ½

Richard A. Dierker, who serves as a director and as President and CEO, reported a Section 16 transaction for Church & Dwight Co., Inc. (CHD). The Form 4 shows a derivative acquisition on 08/15/2025 of 41.895 phantom stock units under the companys Deferred Compensation Plan. The phantom units convert to common stock on a 1-for-1 basis but are documented to be settled in cash under the Plan. The filing lists a per-share reference price of $92.48 and reports beneficial ownership figures consistent with the reporting persons holdings following the transaction.

Brian D. Buchert, Executive Vice President of Strategy, M&A, and BP at Church & Dwight Co., Inc. (CHD), reported a non-derivative acquisition on 08/15/2025. He acquired 5.069 phantom stock units under the company's Deferred Compensation Plan at an attributable price of $92.48 per share. The phantom units convert to common stock on a 1-for-1 basis but are to be settled in cash per the Plan. After the transaction Mr. Buchert beneficially owns 571.684 shares on a direct basis. The Form 4 was signed by an attorney-in-fact on 08/18/2025.

Surabhi Pokhriyal, Executive Vice President and Chief Digital Growth Officer at Church & Dwight (CHD), received a grant of 1,620 restricted stock units (RSUs) on 08/14/2025. The RSUs carry a reported grant price of $92.6 per share and will convert 1-for-1 to common stock as they vest. Vesting occurs in three equal annual installments beginning 08/14/2026, so one-third vests each year over three years. After the grant, the filing reports 1,620 shares held directly and 31.907 shares held indirectly via a savings and profit sharing vehicle.

Richard A. Dierker, who is listed as a Director and President and CEO, filed a Form 4 disclosing insider transactions in Church & Dwight Co., Inc. (CHD) dated 08/12/2025. The Form shows a reported transaction on 08/12/2025 with a price of $91.57 and an entry of 5,470 shares associated with an acquisition code (P). The filing also lists multiple dispositions: 1,794 shares, 2,055 shares and 6,320 shares as shown in the table. The document reports total beneficial ownership following the reported transaction(s) as 27,212.3695 shares and discloses an indirect interest of 963.4546 shares described as "Savings & Profit Sharing." The form was signed by an attorney-in-fact, Cristina Paradiso, on 08/12/2025. This filing records routine insider acquisition and disposition entries without additional narrative or explanation in the form.

Lee B. McChesney, EVP and Chief Financial Officer of Church & Dwight Co., Inc. (CHD), reported a transaction dated 08/08/2025 showing an acquisition of 5,409 shares at $91.375 per share, leaving him with 5,409 shares following the reported transaction. The Form 4 also includes entries tied to restricted stock units (RSUs) granted earlier in the year.

The filing describes two RSU grants dated 03/24/2025: one for 1,600 RSUs that vest in three equal annual installments beginning 03/24/2026, and another for 20,580 RSUs that vest in two equal annual installments beginning 03/24/2026. Each RSU converts 1-for-1 into common stock upon vesting and is subject to the reporting person’s continued employment.

Church & Dwight (CHD) Form 4 filing: EVP International Michael Read purchased 2,000 CHD common shares on 08/05/2025 in an open-market transaction (Code P) at an average price of $91.27 per share, investing roughly $182.5 k. Following the trade, Read directly owns 7,505 shares and indirectly holds 1,400 shares through his spouse’s pension plan. No derivative security activity was reported.

Church & Dwight (CHD) posted weaker Q2 25 results. Net sales were nearly flat at $1.51 bn (-0.3 % YoY) but gross margin fell 420 bps to 42.9 %, reflecting $30.4 m inventory and fixed-asset impairment tied to the planned exit of Flawless, Spinbrush and Waterpik showerhead lines. Operating income dropped 22 % to $261.7 m and diluted EPS declined to $0.78 from $0.99.

For 1H 25, revenue slipped 1.4 % to $2.97 bn while net income slid 13 % to $411.1 m; diluted EPS was $1.66 (vs. $1.91). Cash from operations contracted 17 % to $416.5 m, pressured by a $186 m working-capital build (mainly lower accrued marketing and payables). CHD still closed the half with $923 m cash and $2.21 bn long-term debt.

Segment mix shifted: Consumer Domestic sales dipped 1.4 % but International rose 5.3 %; Specialty Products Division fell 3 %. Depreciation & amortization was $117.5 m YTD; amortization expense is expected to run ~$104 m for FY 25.

Capital allocation: In May the company launched a $300 m accelerated share repurchase (2.8 m shares already received) under its evergreen program; $659 m remains authorized. Dividends paid YTD totaled $145 m ($0.59/sh).

Subsequent events (post-quarter): 1) $700 m Touchland acquisition (hand-sanitizer brand) with up to $180 m earn-out; majority of purchase price expected to be assigned to the trade name. 2) New $2.0 bn revolving credit agreement (option to $2.75 bn) maturing 2030, replacing prior $1.5 bn facility.

Management is also conducting a strategic review of the vitamins business after a 2024 impairment and is addressing tariff exposure (~$60 m annualised) via supply-chain actions and selective price increases.